AM630 is an inverse agonist at the human cannabinoid CB1 receptor

被引：46

作者：

Landsman, RS

Makriyannis, A

Deng, HF

Consroe, P

Roeske, WR

Yamamura, HI ^{[1
]}

机构：

[1] Univ Arizona, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA

[2] Univ Arizona, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA

[3] Univ Arizona, Hlth Sci Ctr, Dept Biochem, Tucson, AZ 85724 USA

[4] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ 85724 USA

[5] Univ Arizona, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA

[6] Univ Arizona, Hlth Sci Ctr, Program Neurosci, Tucson, AZ 85724 USA

[7] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA

来源：

LIFE SCIENCES | 1998年 / 62卷 / 09期

关键词：

human cannabinoid CB1 receptor; inverse agonism; AM630; WIN 55,212-2; GTP gamma S; CHO cells; inverse agonist; negative intrinsic activity;

D O I：

10.1016/S0024-3205(97)01187-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The present investigation examines WIN 55,212-2 and AM630 at the cloned human cannabinoid CB1, receptor stably expressed in Chinese hamster ovary (CHO) cells. The effect of various concentrations of WIN 55,212-2 and AM630 on basal [S-35]GTP gamma S binding to cell membranes was determined. WIN 55,212-2 (100 mu M) stimulated basal [S-35]GTP gamma S binding 77.9% with an EC50 value of 0.36 mu M. Conversely, AM630 (100 mu M) inhibited basal [S-35]GTP gamma S binding by 20.9% with an EC50 value of 0.90 mu M These results show that WIN 55,212-2 is an agonist and AM630 is an inverse agonist in this system. (C) 1998 Elsevier Science Inc.

引用

页码：PL109 / PL113

页数：5

共 50 条

[1] Agonist inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630
Ross, RA
Brockie, HC
Stevenson, LA
Murphy, VL
Templeton, F
Makriyannis, A
Pertwee, RG
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (03) : 665 - 672
[2] AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor
Bolognini, Daniele
Cascio, Maria Grazia
Parolaro, Daniela
Pertwee, Roger G.
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (08) : 2561 - 2574
[3] SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
Landsman, RS
Burkey, TH
Consroe, P
Roeske, WR
Yamamura, HI
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R1 - R2
[4] AM630, A COMPETITIVE CANNABINOID RECEPTOR ANTAGONIST
PERTWEE, R
GRIFFIN, G
FERNANDO, S
LI, XY
HILL, A
MAKRIYANNIS, A
LIFE SCIENCES, 1995, 56 (23-24) : 1949 - 1955
[5] Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice
Pryce, Gareth
Baker, David
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (21) : 3790 - 3794
[6] Hemopressin is an inverse agonist of CB1 cannabinoid receptors
Heimann, Andrea S.
Gomes, Lvone
Dale, Camila S.
Pagano, Rosana L.
Gupta, Achla
de Souza, Laura L.
Luchessi, Augusto D.
Castro, Leandro M.
Giorgi, Renata
Rioli, Vanessa
Ferro, Elmer S.
Devi, Lakshmi A.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) : 20588 - 20593
[7] An aromatic microdomain at the cannabinoid CB1 receptor constitutes an agonist/inverse agonist binding region
McAllister, SD
Rizvi, G
Anavi-Goffer, S
Hurst, DP
Barnett-Norris, J
Lynch, DL
Reggio, PH
Abood, ME
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (24) : 5139 - 5152
[8] F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist
Shen, CP
Xiao, JC
Armstrong, H
Hagmann, W
Fong, TM
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 531 (1-3) : 41 - 46
[9] Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
Shearman, LP
Rosko, KM
Fleischer, R
Wang, J
Xu, S
Tong, XS
Rocha, BA
BEHAVIOURAL PHARMACOLOGY, 2003, 14 (08): : 573 - 582
[10] AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain
Hosohata, K
Quock, RM
Hosohata, Y
Burkey, TH
Makriyannis, A
Consroe, P
Roeske, WR
Yamamura, HI
LIFE SCIENCES, 1997, 61 (09) : PL115 - PL118

← 1 2 3 4 5 →